New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ABBV;ABT;ALJ;ALDW;FB;WGP;WES;LRCX;WHF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
July 30, 2015
18:56 EDTFBFacebook plans drone test later this year, AP says
Subscribe for More Information
18:13 EDTFBOn The Fly: Top stock stories for Thursday
The market began the session in negative territory following the release of second quarter GDP data below economists' estimates. Continuing this morning's slow start, the indexes churned in negative territory for the first half of the day before turning mixed near noon. The Dow and S&P generally lagged behind the Nasdaq, with the S&P narrowly edging into positive territory by session close. ECONOMIC EVENTS: In the U.S., gross domestic product was estimated to have grown at a 2.3% annualized rate in the second quarter, though expectations were for GDP growth of 2.7%. The government also upwardly revised its estimate of first quarter GDP growth to 0.6% from a prior estimate of 0.2% contraction in the period. Initial jobless claims rose 12,000 to 267,000 in the week ended July 25, which was a bit below the expected 270,000 first-time claims. COMPANY NEWS: Facebook (FB) reported earnings and revenues last night that topped expectations, but its shares slid $1.78, or 1.84%, to $95.21 as the social network's growth in daily averages users fell a bit short of the consensus forecast and may have missed the high, "whisper" expectations for its report... Shares of Whole Foods (WFM) sunk 11.61% to $36.08 and hit a 52-week low of $35.57 during the session after the company reported weaker than expected results and provided lower than expected profit guidance. Several analysts downgraded shares of the organic foods grocer in the wake of its quarterly report and outlook. MAJOR MOVERS: Among the notable gainers was T-Mobile (TMUS), which advanced $1.82, or 4.91%, to $38.86 after handily beating analyst estimates and raising its outlook for yearly net customer additions forecast. Also higher following their earnings reports were Mondelez (MDLZ) and WWE (WWE), gaining a respective 5.03% and 17.48%. Among the noteworthy losers was Stratasys (SSYS), which fell $3.82, or 10.47%, to $32.67 after the company rescinded its fiscal year guidance, citing a lack of visibility on growth in the market. The news built on continued fears of overcapacity in the sector, leading to session losses for numerous 3D printer stocks, including an 8.94% drop for peer 3D Systems (DDD). Also lower was Qorvo (QRVO), which declined $9.99, or 14.17%, to $60.49 after its second quarter guidance significantly trailed analyst estimates, after which the stock saw price target reductions from BMO and Brean. Additionally, LinnCo (LNCO) declined $1.83, or 29.33%, to $4.41 after parent company Linn Energy (LINE) announced plans to suspend dividends and reserve roughly $450M from annualized distributions, which saw Linn also slipping 26.32% to $4.76. INDEXES: The Dow fell 5.41, or 0.03%, to 17,745.98, the Nasdaq gained 17.05, or 0.33%, to 5,128.79, and the S&P 500 advanced 0.06, or 0.00%%, to 2,108.63.
16:00 EDTFBOptions Update; July 30, 2015
iPath S&P 500 VIX Short-Term Futures down 11c to 16.05. Option volume leaders: AAPL FB SPLS X TWTR BAC NFLX MU CHK BIDU WFM HPQ LNKD MDLZ XOM
12:55 EDTFBOn The Fly: Top stock stories at midday
Subscribe for More Information
11:37 EDTFBFacebook price targets hiked while shares slide after earnings
Subscribe for More Information
11:02 EDTABTAbbott to purchase Tendyne Holdings, Cephea Valve Technologies
Subscribe for More Information
10:09 EDTFBOptions with decreasing implied volatility
Subscribe for More Information
09:25 EDTFBOn The Fly: Pre-market Movers
Subscribe for More Information
08:16 EDTFBFacebook Q2 results over-delivered, says Brean Capital
Brean Capital said Facebook reported Q2 results that were ahead of expectations despite headwinds from foreign exchange. Brean Capital reiterated its Buy rating and raised its price target to $111 from $108 on Facebook shares, citing its strong execution, careful monetization and its leading long-term position in the digital advertising industry.
08:03 EDTFBFacebook price target raised to $110 from $100 at Oppenheimer
Subscribe for More Information
07:54 EDTFBFacebook price target raised to $115 from $105 at BofA/Merrill
Subscribe for More Information
07:46 EDTFBFacebook price target raised to $108 from $95 at Stifel
Subscribe for More Information
07:45 EDTFBFacebook results impressive despite high expectations, says Baird
Subscribe for More Information
07:41 EDTFBFacebook price target raised to $115 following strong Q2 at Raymond James
Raymond James raised Facebook's price target to $115 from $110 following the strong Q2 report. The firm said engagement trends remain solid and is encouraged by the continued strength in the core platform and monetization of new platforms. Raymond James rates shares an Outperform .
07:33 EDTFBFacebook fundamentals still 'very strong,' says RBC Capital
Subscribe for More Information
07:14 EDTFBFacebook price target raised to $115 from $100 at Deutsche Bank
Subscribe for More Information
05:35 EDTFBFacebook price target raised to $110 from $96 at Baird
Subscribe for More Information
05:32 EDTFBFacebook price target raised to $146 from $120 at Piper Jaffray
Subscribe for More Information
July 29, 2015
19:32 EDTLRCX, FBOn The Fly: After Hours Movers
Subscribe for More Information
19:06 EDTFBFacebook says over 450M people using events each month, over 850M using groups
Subscribe for More Information
16:32 EDTWESWestern Gas Partners reports Q2 EPS 44c, consensus 39c
Subscribe for More Information
16:09 EDTLRCXLam Research reports Q4 shipments $1.616B, up 8% sequentially
Subscribe for More Information
16:08 EDTLRCXLam Research reports Q4 adjusted gross margin 45.5%
Subscribe for More Information
16:08 EDTFBFacebook drops 4.6% to $92.60 following Q2 earnings report
Subscribe for More Information
16:07 EDTLRCXLam Research sees Q1 adjusted gross margin 45.5%, plus or minus 1%
Subscribe for More Information
16:07 EDTLRCXLam Research sees Q1 shipments $1.58B, plus or minus $75M
Subscribe for More Information
16:06 EDTLRCXLam Research sees Q1 GAAP EPS $1.46, plus or minus 10c, consensus $1.38
Subscribe for More Information
16:05 EDTLRCXLam Research reports Q4 adjusted EPS $1.50, consensus $1.47
Subscribe for More Information
16:03 EDTFBFacebook says mobile ad revenue made up 76% of total Q2 ad revenue
Subscribe for More Information
16:02 EDTFBFacebook reports Q2 daily active users up 17%
Subscribe for More Information
16:01 EDTFBFacebook reports Q2 EPS 50c, consensus 47c
Reports Q2 revenue $4.04B, consensus $3.99B.
16:00 EDTFBOptions Update; July 29, 2015
Subscribe for More Information
15:59 EDTFB, LRCXNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Facebook (FB), consensus 47c... MetLife (MET), consensus $1.48... Williams (WMB), consensus 24c... Vertex (VRTX), consensus (58c)... O'Reilly Automotive (ORLY), consensus $2.26... NXP Semiconductors (NXPI), consensus $1.37... Marriott (MAR), consensus 81c... Fiserv (FISV), consensus 94c... Western Digital (WDC), consensus $1.45... SBA Communications (SBAC), consensus 9c... Whole Foods (WFM), consensus 45c... Lincoln National (LNC), consensus $1.53... Lam Research (LRCX), consensus $1.47... ServiceNow (NOW), consensus (2c)... Qorvo (QRVO), consensus $1.06... Hologic (HOLX), consensus 39c.
15:08 EDTLRCX, FBNotable companies reporting after market close
Subscribe for More Information
14:49 EDTFBFacebook July weekly 96 straddle priced for 8.2% movement into Q2
Subscribe for More Information
12:37 EDTFBEarnings Watch: Analysts upbeat on Facebook revenue drivers ahead of Q2 report
Facebook (FB) is expected to report second quarter earnings after the market close on Wednesday, July 29 with a conference call scheduled for 5:00 pm ET. Facebook is a social networking service with over 1B active users. EXPECTATIONS: Analysts are looking for earnings per share of 47c on revenue of $3.99B. The consensus range is 39c-54c for EPS, and $3.66B-$4.22B for revenue, according to First Call. LAST QUARTER: Facebook reported first quarter EPS of 42c against estimates of 40c, on revenue of $3.54B against estimates of $3.56B. Facebook reported Q1 daily active users were up 17% to 936M and mobile daily active users were up 31% to 798M. Monthly active users were 1.44B as of March 31, 2015. The company said Instagram has more than 200M daily users. During its Q1 earnings conference call, Facebook said it expects Foreign Exchange headwinds in Q2 will be greater than Q1. It said it expects total payments and other fees revenue to decline year-over-year for the remainder of the year. NEWS: In the past quarter, Facebook introduced video calling and Moneypenny features to its Messenger service. It also announced the Internet.org platform and its Instant Articles for publishers. Re/code said Facebook may be mulling a Twitter (TWTR) acquisition, but Facebook declined to comment. A New York Times article said Facebook is in talks to insert music videos in feeds. Facebook also said there was no truth to a rumor that said it may launch a music streaming service. STREET RESEARCH: Most analyst firms in the past quarter gave positive recommendations on Facebook, citing strong revenue drivers from multiple sources, SunTrust said Facebook could get a significant revenue boost from its Instagram move and expects the Buy button could lift revenue 5%-10%. Piper Jaffray said Facebook’s multiple is expected to increase as investors become more aware of VR, adding that the company is the best play on the “next computer paradigm of virtual reality.” JMP Securities say Facebook is expected to continue its growth in ad share as Instagram engagement and monthly average users continue to grow. Ahead of the Q2 earnings report, ITG Research said Q2 revenue is tracking slight above consensus and BTIG expects Facebook to exceed consensus estimates due to higher confidence in video advertising opportunity. Brean Capital said Facebook will face ForEx headwinds in Q2, but quarterly results are less relevant as investors will be focused on the long-term goals. PRICE ACTION: Facebook shares have gained about 13% since the first day of trading following the company's Q1 report. In Wednesday afternoon trading ahead of its Q2 report, Facebook shares are up 0.5%
11:48 EDTFBStocks with call strike movement; FB GILD
Facebook (FB) December 110 call option implied volatility decreased 3% to 32, Gilead (GILD) November 130 call option implied volatility decreased 9% to 29 according to IVolatility.
11:15 EDTFBFacebook July weekly 95 straddle priced for 8.7% movement into Q2
Subscribe for More Information
11:07 EDTFBFacebook technical comments ahead of results
On the daily chart there is a potential bullish flag that has developed in the last two weeks. If the news is strongly bullish, the flag pattern would become active on a move above $96.50. Upside potential for the pattern, if it triggers and completes, is to the $110 to $112 area. If the news is instead a negative surprise, first established support would be at the $90 area. On a breakdown below $90, next support would be at the 50-day moving average at $86.16. If the 50-day is broken, next support is at $84.74. The $83 to $80 zone has been strong support over the prior year in the event of a larger negative surprise.
09:35 EDTFBActive equity options trading on open
Subscribe for More Information
06:40 EDTFBFacebook testing profile tags feature, Verge reports
Subscribe for More Information
06:23 EDTFBFacebook July weekly volatility elevated into Q2 and outlook
Subscribe for More Information
06:07 EDTFBFacebook expected to present mobile revenue increase, Re/code says
Subscribe for More Information
July 28, 2015
16:00 EDTFBOptions Update; July 28, 2015
Subscribe for More Information
11:42 EDTFBStocks with call strike movement; FB GILD
Subscribe for More Information
10:47 EDTFBUBS says YouTube paid service could be $1B business
Google's (GOOG, GOOGL) revenue could increase by about $1B or more if it decides to offer a paid, ad free version of its YouTube website in the U.S., UBS wrote in a note to investors today. The firm made the estimate based on a survey it conducted of U.S. consumers. WHAT'S NEW: YouTube remains well-positioned to benefit from the growth of online video, UBS analyst Eric Sheridan stated. After UBS conducted a survey of U.S. adult consumers, Sheridan reported that the survey found that 27% of U.S. consumers would probably subscribe to a paid, ad free version of YouTube. According to Bloomberg, YouTube has decided to launch such a service in coming months. If only 5% of U.S. YouTube users buy subscriptions to the service, Google's revenue would rise by about $943M, Sheridan estimated. Following the survey, the analyst is more confident that Google will meet his revenue estimates, which exceed consensus levels. Specifically, he predicted that Google's revenue for the second half of 2015 would come in at $32.4B, versus the consensus outlook of $31.8B, while its 2016 revenue would be $72.2B, compared with the consensus estimate of $69.7B. Sheridan kept a $750 price target and Buy rating on the stock. WHAT'S NOTABLE: Other companies that are significantly exposed to online video include Netflix (NFLX), Facebook (FB) and AOL, which has been acquired by Verizon (VZ). PRICE ACTION: In morning trading, Google Class A shares were little changed at $657.55.
09:42 EDTFBActive equity options trading on open
Active equity options trading on open: AAPL BIDU FB NFLX F T FCX TWTR
08:16 EDTFBFacebook July weekly volatility elevated into Q2 and outlook
Facebook July weekly call option implied volatility is at 109, August is at 52, September is at 41; compared to its 52-week range of 19 to 48, suggesting large near term price movement into the expected release of Q2 results on July 29.
07:59 EDTLRCXKLA-Tencor downgraded to Sell from Neutral at Citi
Subscribe for More Information
07:20 EDTABBVBrookings Institute to hold a public meeting
Subscribe for More Information
06:21 EDTFBTwitter, Facebook profitability gap 'vast,' Re/code reports
Twitter's (TWTR) recent stock stumble has created the appearance of a potential bargain compared with Facebook (FB), though in reality the difference in growth and profitability between the two companies is enormous, the Wall Street Journal reports. Analysts forecast Twitter posting negative $200M in EBITDA this year, with Facebook expected to post positive $8B, the report says. Reference Link
July 27, 2015
16:00 EDTFBOptions Update; July 27, 2015
Subscribe for More Information
11:57 EDTFBStocks with call strike movement; FB GILD
Subscribe for More Information
09:14 EDTFBFacebook price target raised to $110 from $94 at Cowen
Cowen analyst John Blackledge raised his price target for Facebook (FB) to $110 ahead of the social media giant's Q2 results on July 29. Investor sentiment has grown more positive recently given Facebook's "explosive" video growth and the opening of the Instagram platform to advertisers, Blackledge tells investors in a research note previewing the Q2 results this week for Internet names. He keeps an Outperform rating on the stock. Blackledge also keeps Outperform ratings on LinkedIn (LNKD) and IAC (IACI) as well as a Market Perform rating on Twitter (TWTR). Those three companies are also reporting Q2 results this week.
09:11 EDTFBFacebook price target raised to $125 from $100 at SunTrust
Subscribe for More Information
08:23 EDTFBFacebook July weekly volatility elevated into Q2 and outlook
Facebook August weekly call option implied volatility is at 87, August is at 50, September is at 41; compared to its 52-week range of 19 to 48, suggesting large near term price movement into the expected release of Q2 results on July 29.
08:20 EDTFBFacebook expectations high into results, says BofA/Merrill
Subscribe for More Information
07:45 EDTABBVAbbVie remains favorite large-cap name, says UBS
Subscribe for More Information
07:01 EDTABBVBristol-Myers, AbbVie say EMA validates for review Empliciti MAA
Bristol-Myers Squibb Company (BMY) and AbbVie (ABBV) announced the European Medicines Agency validated for review the Marketing Authorization Application for Empliciti, an investigational Signaling Lymphocyte Activation Molecule-directed immunostimulatory antibody, for the treatment of multiple myeloma as combination therapy in adult patients who have received one or more prior therapies. The application was granted accelerated assessment by the EMA’s Committee for Medicinal Products for Human Use. Bristol-Myers Squibb and AbbVie are co-developing Empliciti, with Bristol-Myers Squibb solely responsible for commercial activities. Bristol-Myers Squibb has proposed the name Empliciti which, if approved by health authorities, will serve as the trade name for elotuzumab. The MAA is primarily supported by data from two randomized clinical trials, each combining Empliciti with a different standard of care regimen for multiple myeloma. ELOQUENT-2, a Phase 3, randomized, open-label study, evaluated Empliciti in combination with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone. The results of this trial were published in The New England Journal of Medicine on June 2. Additionally, a Phase 2, randomized, open-label study evaluated Empliciti with bortezomib and dexamethasone versus bortezomib and dexamethasone alone. These Phase 2 results were presented in an oral session at the 20th Congress of the European Hematology Association. Empliciti previously obtained orphan drug designation in the European Union. An orphan medicinal product must be intended for the treatment, prevention or diagnosis of a disease that is life threatening and chronically debilitating; the prevalence in the EU must not be more than five in 10,000. The medicine must be of significant benefit to those affected by the condition. If maintained, orphan drug designation allows sponsors to access a number of incentives including protocol assistance and receive market exclusivity for a ten-year period following approval.
06:23 EDTFBInstagram's mobile ad revenues to reach $2.81B in 2017, eMarketer says
Subscribe for More Information
05:53 EDTFBBrean calls LinkedIn valuation 'problematic' ahead of Q2 results
Subscribe for More Information
July 24, 2015
15:06 EDTFBEarnings Watch: TV networks report as streaming services gain ground
CBS (CBS), Time Warner (TWX), Viacom (VIA, VIAB), and 21st Century Fox (FOX, FOXA) are among TV network companies expected to report quarterly results over the next several weeks, with Comcast (CMCSA, CMCSK) already having reported before the open on July 23. EXPECTATIONS: Time Warner is expected to report EPS of $1.03 on revenue of $6.9B, CBS is expected to report EPS of 73c on revenue of $3.22B, Viacom is expected to report EPS of $1.47 on revenue of $3.22B, and 21st Century Fox is expected to report EPS of 37c on revenue of $6.48B. LAST QUARTER: CBS, Time Warner, and Fox all reported stronger than expected Q1 results, while Viacom reported higher than expected Q2 EPS but missed on revenue. THIS WEEK'S EARNINGS: On the morning of July 23, Comcast reported Q2 EPS of 84c in line with estimates, and revenue of $18.7B versus expectations for $18.14B. Cable customer relationships for the quarter were up 31,000 to 27.3M, driven by increases in double and triple product relationships. During a subsequent conference call, the company noted that TV viewership continues to be under pressure. NEWS: At Re/code's Code Conference on May 27, CBS CEO Leslie Moonves remarked that his network will "probably" sign up for Apple's (AAPL) rumored TV service, and on June 3, CBS announced that its Showtime network will be offered over the internet as a stand-alone streaming service launching in early July for a monthly price of $10.99, with Apple as its first partner. On July 1, Variety quoted sources as saying Viacom was attempting to entice advertisers by offering to construct social-media and digital extensions of traditional TV ad campaigns as the company seeks to move away from Nielsen-based advertising sales. On July 8, the Wall Street Journal reported that Viacom's Paramount Pictures reached an agreement with AMC (AMC) to accelerate the home release of movies, noting that the company hoped to implement the quickened schedule for all new releases beginning later in the year. On July 17, Re/code reported that Viacom held talks to acquire e-commerce and media company Thrillist Media, according to sources. On June 17, 21st Century Fox named James Murdoch as CEO, with founder and former chairman and CEO Rupert Murdoch appointed executive co-chairman alongside Lachlan Murdoch. The Telegraph reported on June 20 that Fox rejected offers for its stake in Sky (SKYAY) from Vodafone (VOD) and Vivendi (VIVHY), potentially signalling an interest in outright purchasing the rest of Sky, according to the report. More recently, the European Commission announced on July 23 that it delivered a statement of objections to Sky and various film studios owned by Comcast, Viacom, Fox, Time Warner, Disney (DIS), and Sony (SNE), discussing anti-trust concerns due to limitations on country-by-country availability of pay-TV services. STREET RESEARCH: On May 12, Pacific Crest said it believes Apple will launch its TV service before the end of the year, saying the move should benefit TV networks as well as Apple itself. On June 24, Brean Capital said Facebook's (FB) agreement with Time Warner to host premier episodes of certain upcoming shows was "a trend worth following," and possibly indicative of Facebook hosting additional TV content in the future. Also on June 24, FBR Capital contended that Netflix (NFLX) was on pace to have a larger 24-hour audience than all traditional broadcast networks, where ratings are seeing declines on average, according to the research firm. Those comments were followed by a July 10 note on Netflix from Morgan Stanley, saying the subscription streaming service was seeing higher time spent per day than any single broadcast network. Moving away from the Netflix factor, on July 10, JPMorgan said CBS shares looked "very attractive" following a recent selloff, though the company saw a downgrade on July 20 from Pivotal, which cited higher costs of capital among other factors. Finally, Citi upgraded Viacom on July 16 to Neutral, citing recent underperformance in the company's shares heading into earnings season.
14:56 EDTABBVEnanta announces FDA approval of AbbVie's Technivie
Enanta Pharmaceuticals (ENTA) announced that the FDA approved AbbVie’s (ABBV) Technivie -- ombitasvir, paritaprevir and ritonavir -- tablets in combination with ribavirin for the treatment of non-cirrhotic adults with genotype 4 chronic hepatitis C virus, or HCV, infection. Technivie is the first and only all-oral, interferon-free, direct-acting antiviral treatment approved in the U.S. for adult patients with GT4 chronic HCV infection. Paritaprevir is Enanta’s lead protease inhibitor identified within the ongoing Enanta-AbbVie collaboration and is one of the two direct-acting antivirals (2-DAA) in AbbVie’s Technivie.
14:04 EDTFBOn The Fly: Weekly technical notes on 'FANG' and divergences
Subscribe for More Information
14:02 EDTABBVAbbVie says FDA approves hepatitis drug Technivie
Subscribe for More Information
13:52 EDTFBFacebook July weekly volatility increasing into Q2 and outlook
Subscribe for More Information
12:54 EDTABBVOn The Fly: Top stock stories at midday
Subscribe for More Information
11:12 EDTABBVFDA approves AbbVie hepatitis drug Technivie
The FDA approved Technivie for use in combination with ribavirin for the treatment of hepatitis C virus, or HCV, genotype 4 infections in patients without scarring and poor liver function. Technivie in combination with ribavirin is the first drug that has demonstrated safety and efficacy to treat genotype 4 HCV infections without the need for co-administration of interferon, an FDA-approved drug also used to treat HCV infection. Technivie is marketed by AbbVie. Reference Link
10:15 EDTFBFacebook wins litigation against investors over IPO, Reuters reports
Subscribe for More Information
10:05 EDTABBVAbbVie says has not reached a decision yet on celiac disease
Subscribe for More Information
10:00 EDTALJ, ALDWOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:54 EDTABBVAbbVie backs FY15 Humira sales forecast
Subscribe for More Information
09:53 EDTABBVAbbVie CEO says 'probably will' narrow guidance range
Subscribe for More Information
09:37 EDTABBVAbbVie sees Q3 operating revenue growth of about 20%, excluding forex
Subscribe for More Information
09:36 EDTABBVAbbVie sees Q3 adjusted EPS $1.05-$1.07, consensus $1.08
Subscribe for More Information
09:36 EDTFBActive equity options trading on open
Subscribe for More Information
09:33 EDTABBVAbbVie sees FY15 Lupron sales roughly in line with 2014
AbbVie sees "modest growth" for Synthroid in FY15. Sees AndroGel sales "somewhat above" $500M for 2015.
09:21 EDTABBVAbbVie sees IMBRUVICA U.S. sales of about $1B for 2015
AbbVie Chairman and CEO Richard Gonzalez said the company continues to expect IMBRUVICA to drive U.S. sales of approximately $1B for the full calendar year 2015. Since the company completed the Pharmacyclics transaction, it has seen "additional positive data" and progress on its regulatory objectives, including readouts from two Phase 3 studies, HELIOS and RESONATE-2, noted Gonzalez during the company's Q2 earnings conference call.
07:56 EDTABBVAbbVie reports Q2 Viekira sales $385M, Q2 Imbruvica sales $234M
Subscribe for More Information
07:55 EDTABBVAbbVie reports Q2 Global Humira sales up 16.4% to $3.54B
Strong U.S. HUMIRA growth continued, driven by double-digit growth across all three major market categories, rheumatology, dermatology and gastroenterology. Reported international HUMIRA sales growth in the quarter was reduced by nearly 18 percent due to unfavorable foreign exchange. First-half 2015 international HUMIRA sales grew nearly 9 percent on an operational basis, consistent with planning expectations and the full year forecast for international HUMIRA sales growth of 9 to 10 percent on an operational basis. As noted last quarter, the first-quarter international operational growth rate of nearly 15 percent was favorably impacted by the timing of shipments in select markets. Consequently, sales growth in the second quarter was negatively impacted by shipment timing.
07:54 EDTABBVAbbVie backs FY15 adjusted EPS $4.10-$4.30, consensus $4.24
Subscribe for More Information
07:54 EDTABBVAbbVie reports Q2 adjusted EPS $1.08, consensus $1.06
Reports Q2 revenue $5.48B, consensus $5.62B
07:14 EDTALDWAlon USA Partners initiated with a Neutral at Macquarie
Target $19.50.
07:12 EDTALJAlon USA Energy initiated with a Neutral at Macquarie
Subscribe for More Information
06:57 EDTFBFacebook July weekly volatility increasing into Q2 and outlook
Subscribe for More Information
July 23, 2015
15:05 EDTABBVNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include AbbVie (ABBV), consensus $1.06... Biogen (BIIB), consensus $4.10... Simon Property Group (SPG), consensus $2.36... State Street (STT), consensus $1.37... V.F. Corp. (VFC), consensus 36c... Johnson Controls (JCI), consensus 91c... American Airlines (AAL), consensus $2.60... Rockwell Collins (COL), consensus $1.30... Cabot Oil & Gas (COG), consensus 4c... Lear (LEA), consensus $2.48... Encana (ECA), consensus (15c).
14:55 EDTABBVAbbVie technical comments before earnings news
The stock is trading close to its life high at $71.60 ahead of earnings news. On a 2-year chart basis recent high price and the near-matching high from December of last year indicates shares are at major resistance. If the news is a bearish surprise, these two peaks in price could be construed as potential double top. Next supports below $70 would be at $68.50, $66.52, and $64.81. If the news is a bullish surprise, the life high could easily be taken out. An extension of the current bullish price channel in time yields a potential target at $75. Without overhead resistance, that level could be exceeded depending on the nature of the news.
13:56 EDTABBVEarnings Watch: AbbVie sees Q2 EPS $1.04-$1.06
Subscribe for More Information
13:53 EDTFB“Fab Five” option implied volatility
Subscribe for More Information
09:38 EDTFBActive equity options trading on open
Subscribe for More Information
06:38 EDTFBFacebook July weekly volatility increasing into Q2 and outlook
Facebook 7/31/15 weekly call option implied volatility is at 60, August is at 40, September is at 34; compared to its 52-week range of 19 to 48, suggesting large near term price movement into the expected release of Q2 results on July 29.
July 22, 2015
23:09 EDTFBFormer MTV executive joins YouTube as VP of originals, Variety says
Subscribe for More Information
17:03 EDTALJD. E. Shaw Kalon Portfolios reports 5.6% stake in Alon USA Energy
Subscribe for More Information
15:02 EDTFBOptions Update; July 22, 2015
Subscribe for More Information
10:06 EDTABTAbbott CEO says supportive of Mylan pursuit of Perrigo
Subscribe for More Information
10:01 EDTABBVOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:46 EDTFBFacebook Q2 revenues tracking slight above consensus, says ITG Research
ITG Research's data analysis indicates Facebook's Q2 North American revenue is tracking to $1.9B, up from a previous estimate of $1.86B, versus consensus of $1.84B due to increased spending per advertiser. Firm estimates total Q2 revenues are tracking to $4.05B versus consensus of $3.98B.
09:38 EDTFBActive equity options trading on open:
Subscribe for More Information
09:33 EDTABTAbbott sees Q3 Diagnostics sales up mid single digits on operational basis
Subscribe for More Information
09:30 EDTABTAbbott CEO says 'pretty alligned' with Mylan so far
09:15 EDTABTAbbott sees FY15 reported sales growth to be in low single digits
Subscribe for More Information
09:15 EDTABTAbbott sees Q3 EPS 52c-54c, consensus 55c
Sees Q3 impact from foreign exchange to be "somewhat above" 9% based on current exchange rates, resulting in reported sales growth in the low single digits, consensus $5.19B. Guidance from Q2 earnings call.
09:07 EDTABTOn The Fly: Pre-market Movers
Subscribe for More Information
09:07 EDTABTAbbott says foreign exchange impacting results more than expected in January
Subscribe for More Information
07:49 EDTABTAbbott reports Q2 Nutrition sales $1.72B, Diagnostics sales $1.18B
Subscribe for More Information
07:48 EDTABTAbbott backs FY15 adjusted EPS $2.10-$2.20, consensus $2.16
Abbott forecasts net specified items related to continuing operations for the full year 2015 of approximately 60c per share.
07:47 EDTABTAbbott reports Q2 adjusted EPS 52c, consensus 50c
Subscribe for More Information
07:04 EDTABBVAbbVie initiated with a Buy at SunTrust
Subscribe for More Information
July 21, 2015
16:01 EDTFBOptions Update; July 21, 2015
iPath S&P 500 VIX Short-Term Futures down 13c to 16.20. Option volume leaders: AAPL BAC FB BAC MSFT NFLX AMD IBM CHK
15:02 EDTABTNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Coca-Cola (KO), consensus 60c... Boeing (BA), consensus $1.42... Abbott Laboratories (ABT), consensus 50c... Thermo Fisher Scientific (TMO), consensus $1.78... EMC (EMC), consensus 41c... Illinois Tool Works (ITW), consensus $1.28... St. Jude Medical (STJ), consensus $1.00... Northern Trust (NTRS), consensus 96c... Check Point Software (CHKP), consensus 95c... Polaris Industries (PII), consensus $1.58... Interpublic Group (IPG), consensus 27c... New York Community Bancorp (NYCB), consensus 26c... B/E Aerospace (BEAV), consensus 76c... Owens Corning (OC), consensus 54c... Knight Transportation (KNX), consensus 37c.
09:35 EDTFBActive equity options trading on open
Active equity options trading on open: AAPL FB IBM TSLA BAC PVA NFLX
08:05 EDTFBFacebook added to US 1 List at BofA/Merrill
Subscribe for More Information
07:45 EDTFBSell PayPal amid mounting payments competition, Piper says
Shares of PayPal (PYPL) advanced over 5% yesterday in the stock's first day of trading following a split from eBay (EBAY), with the majority of research firms issuing optimistic notes on its prospects. This morning, however, analyst Gene Munster of Piper Jaffray recommends selling the share as competition grows in the digital payments space. BEARS: Munster started shares of PayPal with an Underweight rating, the firm's equivalent of a "Sell," saying increased competition could pressure the stock's multiple over the next 6-24 months. Google's (GOOG) Android Pay and Apple's (AAPL) Apple Pay will give consumers a "real alternative to PayPal" for the first time, Munster tells investors in his research note. In addition, interest in payments from Amazon.com (AMZN) and Facebook (FB) bring potential for more digital wallet offerings, the analyst notes. Munster set a $30 price target for PayPal. Of note, Evercore ISI also started coverage of PayPal shares yesterday with a Sell rating. BULLS: Wells Fargo initiated coverage of PayPal yesterday with an Outperform rating, saying the company's unique assets will enable it to maintain its leadership role in digital payments and benefit from the growth of e-commerce. Also upbeat was Robert W. Baird analyst Colin Sebastian, who contends that PayPal has the top pure play online payment system and is continuing to grow its share of the Internet payment market. PayPal should be able to innovate more effectively after its spin-off, added the analyst, who set a $45 price target on the shares. PRICE ACTION: Shares of PayPal are pointing toward further gains in their second day of standalone trading, with the stock up about 2.7% to $41.55 in pre-market trading.
06:58 EDTFBFacebook added to US 1 List at BofA/Merrill
Subscribe for More Information
06:19 EDTFBSilicon Valley giants side with Samsung in battle with Apple, InsideSources says
Subscribe for More Information
05:34 EDTFBPayPal initiated with an Underweight at Piper Jaffray
Piper Jaffray analyst Gene Munster started shares of PayPal (PYPL) with an Underweight rating saying increased competition could pressure the stock's multiple over the next 6-24 months. Underweight is Piper's equivalent of a sell rating. Google's (GOOG) Android Pay and Apple's (AAPL) Apple Pay will give consumers a "real alternative to PayPal" for the first time, Munster tells investors in a research note. In addition, interest in payments from Amazon.com (AMZN) and Facebook (FB) bring potential for more digital wallet offerings, the analyst notes. Munster set a $30 price target for PayPal, which began trading yesterday following a spinoff from parent company eBay (EBAY). Shares of the online payment system closed Monday up $2.08 to $40.47.
July 20, 2015
16:01 EDTFBOptions Update; July 20, 2015
Subscribe for More Information
12:40 EDTFBEarnings Watch: IBM up 4% since last quarterly report
Subscribe for More Information
12:35 EDTFBFacebook July weekly volatility increasing into Q2 and outlook
Facebook 7/31/15 weekly call option implied volatility is at 53, August is at 38, September is at 33; compared to its 52-week range of 19 to 48, suggesting large near term price movement into the expected release of Q2 results on July 29.
11:29 EDTFBFacebook breakout accelerates, levels to watch
Subscribe for More Information
09:02 EDTABTAbbott receives FDA approval and launches iDesign Advanced WaveScan system
Subscribe for More Information
08:56 EDTFBFacebook price target raised to $117 at BTIG on video opportunity
BTIG analyst Richard Greenfield believes Facebook can exceed consensus estimates, citing higher confidence in the company's video advertising opportunity. Greenfield, who raised his revenue estimates for Facebook in this year and next, also points out Instagram's monetization opportunity and the platform potential of WhatsApp and Messenger. The analyst raised his price target on Facebook to $117 from a "stale" target of $80 that had been set in July of last year and reiterates a Buy rating on the social network's stock, which closed at $94.97 on Friday.
08:38 EDTABTAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
07:33 EDTABTInternational AIDS Society to hold a conference
Subscribe for More Information
07:30 EDTABTZoetis 'highly likely' to merge with Bayer unit in 2016, says Jefferies
Subscribe for More Information
July 17, 2015
16:41 EDTLRCXStocks end week higher as Google, Greece bring out the buyers
Stocks ended the week higher and the major averages are back at record highs after Iran agreed to a nuclear deal, Greece's parliament paved the way for the country to receive another bailout by agreeing to new austerity measures and Google (GOOG) gave investors hope that earnings from tech's other heavyweights will be similarly better than expected. MACRO NEWS: In the U.S., retail sales unexpectedly fell 0.3% in June, versus the consensus forecast for growth of 0.3%. The producer prices index showed prices rose 0.4% in June, versus expectations for an increase of 0.2%. The consumer price index rose a seasonally adjusted 0.3% in June from a month earlier, matching the consensus forecast. Compared with last year, consumer prices rose 0.1%, marking the first annual increase since December. Housing starts rose 9.8% to a 1.17M rate in June and building permits rose 7.4% to a 1.34M pace, both of which topped expectations. The NAHB homebuilder sentiment index for July came in at 60, a point better than forecast. The University of Michigan's consumer sentiment reading dropped to 93.3 in the preliminary July figure, which was below the 96.0 reading that was expected. During testimony before Congress, Federal Reserve Chair Janet Yellen stayed on message, stating that the central bank is on track to raise record-low interest rates this year, so long as the labor market and the economy keep improving... In China, exports rose 2.1% from a year earlier during June and imports dropped 6.7%, leaving a trade surplus of $45.8B for the month, the nation's customs administration reported. The nation's GDP was reported to have grown 7% in the second quarter from a year earlier, beating the consensus expectation for growth of 6.8%... In Europe, Greek lawmakers passed the country's austerity agreement and Euro-area finance ministers reportedly agreed in principle to extend a bridge loan to Greece. The loan should help keep Greece afloat while its Prime Minister negotiates the details of the country's latest bailout... Iran reached a deal on restrictions and inspections intended to prevent it from developing nuclear weapons in exchange for the lifting of economic sanctions by six world powers. The agreement still faces a political fight in the U.S. before taking effect, but President Barack Obama has vowed to veto any congressional effort to block its implementation. COMPANY NEWS: Class A shares of Google (GOOG, GOOGL) surged at the end of the week after the search giant reported better than expected revenues and earnings in the second quarter. Research firms all over Wall Street raised their price targets on the stock in the wake of the report... Netflix (NFLX) rallied to a split-adjusted all-time high after the streaming service operator reported stronger than expected second quarter results, including higher than expected Q2 subscriber metrics, prompting a large number of research firms to raise their price targets on the stock... Many of the nation's largest banks reported on their results in the second quarter this week. JPMorgan (JPM), Bank of America (BAC) and Citigroup (C) all posted quarterly profits, excluding certain items, that beat the average estimates of analysts. Wells Fargo (WFC) reported earnings in-line with consensus estimates and revenue somewhat below expectations, while Goldman Sachs (GS) reported headline earnings that appeared to fall far short of the consensus forecast. However, that was due to Goldman's nearly $1.5B in provisions for litigation and regulatory matters. Excluding those provisions, the bank's earnings were ahead of consensus... On the M&A front, Receptos (RCPT) advanced after Celgene (CELG) announced a deal to buy the smaller drugmaker for $232 per share in cash, or a total of about $7.2B net of cash acquired. A number of research firms applauded the deal, especially noting the price Celgene agreed to pay, but cautioned that a rival bidder may still emerge for Receptos. Marathon Petroleum (MPC) gained after MPLX (MPLX), the company's fee-based master limited partnership, agreed to acquire MarkWest Energy (MWE) in a cash and stock deal that implies a total enterprise value for MarkWest of approximately $20B, including the assumption of debt of approximately $4.2B. Micron (MU) rose after The Wall Street Journal reported that China's state-owned Tsinghua Unigroup had offered to acquire the memory chip maker for $23B, or $21 per share... Shares of Twitter (TWTR) spiked Tuesday morning after a questionable takeover report was published on a website that mimicked, but had a different web address, than Bloomberg News. A Bloomberg spokesman said soon afterward that the Twitter takeover story being attributed to the news service was a fake, while a Twitter spokesperson also denied the report of an alleged deal... Macy's (M) jumped after Starboard CEO Jeffrey Smith called the stock his "best idea" for 2015, adding that the shares could be worth $125 each if the company takes steps to maximize the value of its real estate holdings. Amazon (AMZN) announced it sold more units on its first "Prime Day" than the biggest Black Friday ever and had more new members try its Prime service worldwide than any single day in company history. The e-commerce giant noted that its worldwide order growth increased 266% over the same day last year and 18% more than Black Friday 2014, adding that it will "definitely be" doing another Prime Day in the future. A number of semiconductor equipment stocks, including Applied Materials (AMAT) and Lam Research (LRCX), dropped after Intel (INTC) cut its capital expenditures guidance while reporting on its quarterly results. INDEXES: For the week, the Dow gained about 1.05% to close at 18,086.45, the Nasdaq advanced about 3.37% to close at 5,210.14, and the S&P 500 rose about 1.67% to close at 2,126.64.
16:01 EDTFBOptions Update; July 17, 2015
Subscribe for More Information
12:38 EDTFBOn The Fly: Top stock stories at midday
Subscribe for More Information
11:34 EDTFBGoogle price targets hiked after 'thesis-changing' quarter
Subscribe for More Information
10:09 EDTFBInstagram picks Eva Chen as head of fashion partnerships, Mashable reports
Subscribe for More Information
10:01 EDTFBFacebook July volatility increasing into Q2 and outlook
Facebook 7/31/15 weekly call option implied volatility is at 41, August is at 31, September is at 28; compared to its 52-week range of 19 to 48, suggesting large near term price movement into the expected release of Q2 results on July 29.
09:35 EDTFBActive equity options trading on open
Active equity options trading on open: AAPL NFLX TSLA GOOG FB GOOGL SLB
09:35 EDTFBFacebook hits fresh life, levels to watch
Subscribe for More Information
09:04 EDTABBVAbbVie granted FDA orphan status for Viekira Pak in pediatric patients
Subscribe for More Information
08:06 EDTABBVAbbVie, C2N Diagnostics announce orphan drug designation of C2N-8E12
Subscribe for More Information
06:46 EDTFBJPMorgan puts $800 target on Google after 'thesis-changing' Q2
Subscribe for More Information
06:25 EDTFBGoogle price target raised to $780 from $670 at Deutsche Bank
Subscribe for More Information
05:49 EDTFBGoogle price target raised to $723 from $631 at Piper Jaffray
Piper Jaffray analyst Gene Munster raised his price target for Google shares to $723 saying the search giant's Q2 earnings report and corresponding commentary leave him more confident in the stock over the next two quarters. In addition to talking about a focus on costs, Google noted that mobile cost-per-clicks were up and continued to close the gap on desktop and also highlighted accelerating YouTube usage despite recent media coverage on Facebook (FB) Video, Munster tells investors this morning in a research note. He keeps an Overweight rating on Google. The stock is $62.95 to $642.80 in pre-market trading following last night's earnings report.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use